Lili Yu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Acinetobacter Baumannii

Systematic Review

Advanced Non Small Cell Lung Cancer

Diabetic Retinopathy

Top Venues

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaan Du, Yingqi Mao, You-Hua Xu, Kai Qu, Aiwei Han, Qi-Biao Wu, Lili Yu
Shuangdan Mingmu Capsule for Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Jiaan Du, Yingqi Mao, You-Hua Xu, Kai Qu, Aiwei Han, Qi-Biao Wu, Lili Yu
Shuangdan Mingmu Capsule for Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM 2023 (2023)
Naihua Liu, Xiaoying Yang, Jingyi Guo, Lei Zhang, Shangyi Huang, Jiabing Chen, Jiawen Huang, Yingjian Chen, Tianqi Cui, Yi Zheng, Tianyao Li, Kaijia Tang, Yadi Zhong, Siwei Duan, Lili Yu, Ying Tang, Dayong Zheng, Huafeng Pan, Yong Gao
Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1-driven gluconeogenesis. EMBO reports (2023)
Han Xie, Guirui Huang, Jianhua Zou, Qianru Zhu, Zimao Liang, Xingxing Huang, Xiangyang Zhai, Ruonan Zhang, Bi Chen, Keshuai Li, Xinbing Sui, Lili Yu, Hong-Sheng Cui, Qi-Biao Wu
The Pharmacological Mechanism of Curcumin against Drug Resistance in Non-Small Cell Lung Cancer: Findings of Network Pharmacology and Bioinformatics Analysis. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Keshuai Li, Hai-Bo Chen, Weixing Shen, Elaine Lai-Han Leung, Shao Le, Lili Yu, Han Xie, Xinbing Sui, Xiao-Ming Zhu, Qi-Biao Wu
Compound Taxus chinensis Capsule Combined with Chemotherapy for Non-Small-Cell Lung Cancer: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)